HIV Prevention Breakthrough - A new injectable medicine, Tuggo, represents a potential milestone in HIV prevention [1] - Tuggo is a first-of-its-kind medicine for preventing HIV, administered only twice a year [2] - Clinical trials showed almost 100% protection against HIV with the injectable [2] - The injectable is the result of 20 years of work by Gilead scientists [2] Compliance and Efficacy - Pill-based HIV prevention faces compliance challenges, with only about 50% of people taking pills being compliant [3] - CDC data indicates only about one-third of the population defined by CDC are compliant with pill-based medicine [3] - Non-compliance with pills can lead to breakthrough cases of HIV [4] - The twice-a-year injectable aims to improve prevention by meeting people where they are in terms of adherence [4]

Group 1 - Wells Fargo (NYSE: WFC) is perceived as undervalued, akin to a penalty-box bank, despite strong fundamentals indicating a different narrative [1] - The bank's credit is stable, and its capital structure is robust, suggesting a healthy financial position [1] - The balance sheet is described as overbuilt rather than under pressure, indicating a strong liquidity position [1] - The bank is actively engaging in stock buybacks, reflecting confidence in its financial health [1]

SYDNEY, June 02, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Mark Gossington as a Senior Managing Director in the Risk & Investigations practice within the firm’s Forensic and Litigation Consulting segment. Mr. Gossington, who is based in Sydney, brings more than 25 years of experience leading complex risk engagements and remediation programmes that have helped companies strengthen resilience under regulatory scrutiny, recover from misconduct issues and build ...